2001The Practical Journal of CancerRequires access

Clinical Significance of P-gp、p53 and c-erbB-2 Expression in Breast Cancer

Jia Xiao

Open publisher page 0 citations

Abstract

Objective To study the clinical significance of P gp?p53 and c erbB 2 expression in breast carcinoma tissues.Methods 82 cases of breast cancer specimens were examined for expression of P gp,p53 and c erbB 2 protein by immunohistochemical statining technique.Results The positive rates of P gp,p53 and c erbB 2 were 42.7%,14% respectively in breast cancer specimens.The expression of P gp had a significant correlation with p53 protein ( P 0.05) and not related to c erbB 2 protein.The expression of P gp was not correlated with age,pathological types,lymph node etastatsis and clinical stages.The disease free 5 years survival was not different between 13 cases of P gp positive expression and 27 cases of P gp negative expression ( P 0.05).Conclusion Breast cancer has intrinsic multidrug resistance;Expression of P gp was correlated with p53 protein.

About this research paper

What this paper is about

Objective To study the clinical significance of P gp?p53 and c erbB 2 expression in breast carcinoma tissues.Methods 82 cases of breast cancer specimens were examined for expression of P gp,p53 and c erbB 2 protein by immunohistochemical statining technique.Results The positive rates of P gp,p53 and c erbB 2 were 42.7%,14% respectively in breast cancer specimens.The expression of P gp had a significant correlation with p53 protein ( P 0.05) and not related to c erbB 2 protein.The expression of P gp was not correlated with age,pathological types,lymph node etastatsis and clinical stages.The disease free 5 years survival was not different between 13 cases of P gp positive expression and 27 cases of P gp negative expression ( P 0.05).Conclusion Breast cancer has intrinsic multidrug resistance;Expression of P gp was correlated with p53 protein.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the clinical significance of P gp?p53 and c erbB 2 expression in breast carcinoma tissues.Methods 82 cases of breast cancer specimens were examined for expression of P gp,p53 and c erbB 2 protein by immunohistochemical statining technique.Results The positive rates of P gp,p53 and c erbB 2 were 42.7%,14% respectively in breast cancer specimens.The expression of P gp had a significant correlation with p53 protein ( P 0.05) and not related to c erbB 2 protein.The expression of P gp was not correlated with age,pathological types,lymph node etastatsis and clinical stages.The disease free 5 years survival was not different between 13 cases of P gp positive expression and 27 cases of P gp negative expression ( P 0.05).Conclusion Breast cancer has intrinsic multidrug resistance;Expression of P gp was correlated with p53 protein.

Key concepts: Immunohistochemistry, Breast cancer, Medicine, Clinical significance, Lymph node, Pathological, Breast carcinoma, Oncology

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical Significance of P-gp、p53 and c-erbB-2 Expression in Breast Cancer — Research Paper | ScholarLens